Howard Foundation Holdings Limited v. International Vitamin Corporation
1:12-cv-00035
Overview
Parties
Defendant
International Vitamin Corporation NPE (Individual / Inventor)
Represented By
5 Attorneys ListedDuane Morris LLP
1201 North Market Street, Suite 501
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Plaintiff
Howard Foundation Holdings Limited NPE (University / Research)
Represented By
7 Attorneys ListedPotter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Potter Anderson & Corroon, LLP
1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 10 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| π¬π§ United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6329432
Mesozeaxanthin formulations for treatment of retinal disorders
|
Filed: 2001-03-02
Issued: 2001-12-11
|
Expired (Term Ended)
Expires: 2021-03-02
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
43
Dispositive
0
Granted
2
Denied
3
Pending / Review
18
Motions by Category
Key Dispositive Motions & Rulings